Diagnos Inc New (DGNOF) 0.0760 $DGNOF
DIAGNOS Announces Licensing Deal With Inb al Haythem Center in Algeria
Marketwired - Mon May 04, 8:31AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today a licensing deal with Inb al Haythem Center in Algeria.
ADK.VN: 0.090 (+0.005)
DIAGNOS Announces Licensing Deal With Clinique Hamouche in Algeria
Marketwired - Tue Apr 14, 8:04AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today a deal with Clinique Hamouche in Algeria.
ADK.VN: 0.090 (+0.005)
DIAGNOS Announces Retina Screening Project with Clinique Chifa Hydra in Algeria
Marketwired - Thu Apr 09, 9:52AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today a retina screening project with Clinique Chifa Hydra in Algeria.
ADK.VN: 0.090 (+0.005)
Alexandria Review of Cadillac Break Property Geophysics Yields Strong Targets
Marketwired - Wed Apr 01, 8:16AM CDT
Alexandria Minerals Corporation (TSX VENTURE: AZX)(FRANKFURT: A9D) ("Alexandria" or the "Company"

is pleased to announce the results of a statistical study of the Company's geophysical data on its Cadillac Break Property package in Val d'Or, Quebec. The study, carried out by Diagnos Inc. of Montreal, covered the entire length of the Company's 35 km long property, and provides several solid drill targets over the length of the property.
AZX.VN: 0.050 (unch)
DIAGNOS Announces Two Year Renewal of Successful Program in the UAE
Marketwired - Thu Mar 26, 8:48AM CDT
Diagnos Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announced today a renewal of the agreement originally announced on March 14th 2012 that has since been renewed and expanded to a total of fourteen mobile screening units. The value of the two year agreement is approximately 716,000 CAD.
ADK.VN: 0.090 (+0.005)
DIAGNOS Announces First Screening Project in Poland with Globally Leading Pharmaceutical Company
Marketwired - Wed Mar 18, 11:58AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announced today the signing of a contract with a large global pharmaceutical company that markets a leading ophthalmology product indicated for a variety of ophthalmic complications, including those associated with diabetes, for a screening project in Poland. This project is in conjunction with the same global pharmaceutical company that DIAGNOS works with around the world, including the UAE and India.
ADK.VN: 0.090 (+0.005)
DIAGNOS Announces Contract With a Leading Ophthalmology Pharmaceutical Company in the USA
Marketwired - Tue Mar 10, 10:05AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), leader in diabetic retinopathy screening, is announcing the close of a commercial agreement to provide retina screening services to patients in the United States. The sponsor of the services is a major U.S.-based pharmaceutical company that markets a leading ophthalmology product indicated for a variety of ophthalmic complications including those associated with diabetes.
ADK.VN: 0.090 (+0.005)
DIAGNOS Announces Pilot With a Major Public Health Institution in Mexico for Retinopathy Screening
Marketwired - Mon Feb 16, 8:30AM CST
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), leader in healthcare technical services including screening software and algorithm development, data analysis, and image processing, announces today that a pilot program for diabetic retinopathy screening will be carried out for one of the two main Public Health Institutions in Mexico.
ADK.VN: 0.090 (+0.005)
DIAGNOS Opens Polish Subsidiary Diagnos Poland Sp. z o.o.
Marketwired - Thu Feb 12, 8:31AM CST
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today the opening of its Polish Subsidiary, Diagnos Poland spolka z ograniczona odpowiedzialnoscia (Sp. z o.o.).
ADK.VN: 0.090 (+0.005)
DIAGNOS Announces a Screening Program for Vision-Threatening Diseases (VTD) That Will Now Be Offered in Azur Retirement Residences Operated by the Cogir Management Corporation
Marketwired - Wed Jan 21, 8:31AM CST
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today that a screening program for Vision-Threatening Diseases (VTD) offered to clientele in AZUR retirement residences.
ADK.VN: 0.090 (+0.005)